This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Facebook: Who's Saying What

Stocks in this article: FB JPM MS GS

NEW YORK ( TheStreet) - With Facebook's (FB) post-IPO quiet period over, analysts are flooding to cover the social networking phenomenon. Most are cautious but positive overall about the company's prospects, according to a firehose of research released on Wednesday.

The end of the 40-day quiet period means that the IPO underwriters can initiate coverage of the social networking giant, prompting a slew of research notes from the likes of Morgan Stanley (MS), Citigroup (CITI). JPMorgan Chase (JPM) and Goldman Sachs (GS).

Lead underwriter Morgan Stanley kicked off its coverage with an 'overweight' rating and a $38 price target.

"We believe that Facebook is uniquely positioned to leverage its large and highly-engaged user base to monetize the mobile Internet," explained Morgan analyst Scott Devitt, in his note. "Facebook is executing against three key priorities: aggregation, product initiatives, and monetization."

Not all analysts, however, were quite as bullish. Bank of America Merrill Lynch, for example, initiated its coverage with a 'neutral' rating, but acknowledged Facebook's potential.

"Modest user monetization suggests big room for growth," explained analyst Justin Post, in a note, pointing to the company's Average Revenue Per User of $5, compared to Google's (GOOG) $31. "We expect recently launched new ad formats, including Sponsored Stories in mobile and Promoted Posts to accelerate revenue growth in the second half of 2012, a potential catalyst."

Here's a roundup of Facebook coverage:

  • J.P. Morgan
  • Rating: Overweight Price; Target: $45 (Year-end 2013)
  • Oppenheimer
  • Rating: Outperform; Price Target: $41 (12 to 18 month)
  • RBC Capital Markets
  • Rating: Outperform; Price Target: $40
  • Morgan Stanley
  • Rating: Overweight; Price Target: $38
  • Wells Fargo Securities
  • Rating: Outperform; Valuation Range: $37 to $40
  • William Blair
  • Rating: Outperform
  • Piper Jaffray
  • Rating: Overweight; Price Target: $41
  • Goldman Sachs
  • Rating: Buy; Price Target: $42
  • Citigroup
  • Rating: Neutral; Price Target: $35
  • Bank of America Merrill Lynch
  • Rating: Neutral; Price Target: $38
  • Credit Suisse
  • Rating: Neutral; Price Target: $34
  • Lazard Capital
  • Rating: Neutral
  • Pacific Crest
  • Rating: Sector Perform
  • Barclays
  • Rating: 2-Equal Weight; Price Target: $35
  • Facebook's botched IPO last month prompted intense criticism of the Nasdaq OMX Group (NDAQ), which subsequently offered compensation to financial organizations that lost out in the offering. Morgan Stanley also came under fire for its handling of the IPO.

    Shares of Facebook, which have fallen 13.71% since the company's IPO, slipped 0.91% to $32.80 in Wednesday's session.

    -- Written by James Rogers in New York.

    >To submit a news tip, send an email to:

    Check out our new tech blog, Tech Trends. Follow TheStreet Tech on your wireless devices.

    Select the service that is right for you!

    Action Alerts PLUS
    Try it NOW

    Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    • Weekly roundups
    TheStreet Quant Ratings
    Try it NOW
    Only $49.95/yr

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    • Upgrade/downgrade alerts
    Stocks Under $10
    Try it NOW

    David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    • Weekly roundups
    Dividend Stock Advisor
    Try it NOW

    Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Alerts when market news affect the portfolio
    • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
    Real Money Pro
    Try it NOW

    All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

    Product Features:
    • Real Money + Doug Kass Plus 15 more Wall Street Pros
    • Intraday commentary & news
    • Ultra-actionable trading ideas
    Options Profits
    Try it NOW

    Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

    Product Features:
    • 100+ monthly options trading ideas
    • Actionable options commentary & news
    • Real-time trading community
    • Options TV
    To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
    Submit an article to us!


    DOW 17,804.80 +26.65 0.15%
    S&P 500 2,070.65 +9.42 0.46%
    NASDAQ 4,765.38 +16.9840 0.36%

    Brokerage Partners

    Rates from

    • Mortgage
    • Credit Cards
    • Auto

    Free Newsletters from TheStreet

    My Subscriptions:

    After the Bell

    Before the Bell

    Booyah! Newsletter

    Midday Bell

    TheStreet Top 10 Stories

    Winners & Losers

    Register for Newsletters
    Top Rated Stocks Top Rated Funds Top Rated ETFs